<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 10 Mar 2026 20:37:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  SCHEDULE 13G  Perspective Therapeutics               Filed by: Avidity Partners Management LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Perspective+Therapeutics+++++++++++++++Filed+by%3A+Avidity+Partners+Management+LP/26141340.html</link>
   <description>si-local-file:///var/storage/secattach/20260310/26141340.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Perspective+Therapeutics+++++++++++++++Filed+by%3A+Avidity+Partners+Management+LP/26141340.html</guid>
   <pubDate>Tue, 10 Mar 2026 20:37:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  Perspective Therapeutics               Filed by: Avidity Partners Management LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Perspective+Therapeutics+++++++++++++++Filed+by%3A+Avidity+Partners+Management+LP/26141340.html</link>
   <description>si-local-file:///var/storage/secattach/20260310/26141340.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Perspective+Therapeutics+++++++++++++++Filed+by%3A+Avidity+Partners+Management+LP/26141340.html</guid>
   <pubDate>Tue, 10 Mar 2026 20:37:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Form  4          Perspective Therapeutics  For: Mar 02  Filed by: Williamson Robert F III</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Williamson+Robert+F+III/26111969.html</link>
   <description>si-local-file:///var/storage/secattach/20260304/26111969.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Williamson+Robert+F+III/26111969.html</guid>
   <pubDate>Wed, 04 Mar 2026 16:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Form  4          Perspective Therapeutics  For: Mar 02  Filed by: Williamson Robert F III</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Williamson+Robert+F+III/26111969.html</link>
   <description>si-local-file:///var/storage/secattach/20260304/26111969.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Williamson+Robert+F+III/26111969.html</guid>
   <pubDate>Wed, 04 Mar 2026 16:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Form  4          Perspective Therapeutics  For: Mar 02  Filed by: Morich Frank</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Morich+Frank/26111978.html</link>
   <description>si-local-file:///var/storage/secattach/20260304/26111978.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Morich+Frank/26111978.html</guid>
   <pubDate>Wed, 04 Mar 2026 16:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Form  4          Perspective Therapeutics  For: Mar 02  Filed by: Morich Frank</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Morich+Frank/26111978.html</link>
   <description>si-local-file:///var/storage/secattach/20260304/26111978.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Morich+Frank/26111978.html</guid>
   <pubDate>Wed, 04 Mar 2026 16:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Form  4          Perspective Therapeutics  For: Mar 02  Filed by: Martinez Maria E</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Martinez+Maria+E/26111995.html</link>
   <description>si-local-file:///var/storage/secattach/20260304/26111995.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Martinez+Maria+E/26111995.html</guid>
   <pubDate>Wed, 04 Mar 2026 16:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Form  4          Perspective Therapeutics  For: Mar 02  Filed by: Martinez Maria E</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Martinez+Maria+E/26111995.html</link>
   <description>si-local-file:///var/storage/secattach/20260304/26111995.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Martinez+Maria+E/26111995.html</guid>
   <pubDate>Wed, 04 Mar 2026 16:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Form  4          Perspective Therapeutics  For: Mar 02  Filed by: Woods Lori A</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Woods+Lori+A/26111947.html</link>
   <description>si-local-file:///var/storage/secattach/20260304/26111947.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Woods+Lori+A/26111947.html</guid>
   <pubDate>Wed, 04 Mar 2026 16:37:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Form  4          Perspective Therapeutics  For: Mar 02  Filed by: Woods Lori A</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Woods+Lori+A/26111947.html</link>
   <description>si-local-file:///var/storage/secattach/20260304/26111947.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Woods+Lori+A/26111947.html</guid>
   <pubDate>Wed, 04 Mar 2026 16:37:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Form  4          Perspective Therapeutics  For: Mar 02  Filed by: HENSON HEIDI</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+HENSON+HEIDI/26111961.html</link>
   <description>si-local-file:///var/storage/secattach/20260304/26111961.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+HENSON+HEIDI/26111961.html</guid>
   <pubDate>Wed, 04 Mar 2026 16:37:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Form  4          Perspective Therapeutics  For: Mar 02  Filed by: HENSON HEIDI</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+HENSON+HEIDI/26111961.html</link>
   <description>si-local-file:///var/storage/secattach/20260304/26111961.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+HENSON+HEIDI/26111961.html</guid>
   <pubDate>Wed, 04 Mar 2026 16:37:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Form  4          Perspective Therapeutics  For: Mar 02  Filed by: Spoor Johan M.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Spoor+Johan+M./26111916.html</link>
   <description>si-local-file:///var/storage/secattach/20260304/26111916.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Spoor+Johan+M./26111916.html</guid>
   <pubDate>Wed, 04 Mar 2026 16:36:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Form  4          Perspective Therapeutics  For: Mar 02  Filed by: Spoor Johan M.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Spoor+Johan+M./26111916.html</link>
   <description>si-local-file:///var/storage/secattach/20260304/26111916.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Spoor+Johan+M./26111916.html</guid>
   <pubDate>Wed, 04 Mar 2026 16:36:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Form  4          Perspective Therapeutics  For: Mar 02  Filed by: Puhlmann Markus</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Puhlmann+Markus/26111891.html</link>
   <description>si-local-file:///var/storage/secattach/20260304/26111891.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Puhlmann+Markus/26111891.html</guid>
   <pubDate>Wed, 04 Mar 2026 16:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Form  4          Perspective Therapeutics  For: Mar 02  Filed by: Puhlmann Markus</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Puhlmann+Markus/26111891.html</link>
   <description>si-local-file:///var/storage/secattach/20260304/26111891.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Puhlmann+Markus/26111891.html</guid>
   <pubDate>Wed, 04 Mar 2026 16:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Form  4          Perspective Therapeutics  For: Mar 02  Filed by: Hunt Jonathan Robert</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Hunt+Jonathan+Robert/26111905.html</link>
   <description>si-local-file:///var/storage/secattach/20260304/26111905.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Hunt+Jonathan+Robert/26111905.html</guid>
   <pubDate>Wed, 04 Mar 2026 16:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Form  4          Perspective Therapeutics  For: Mar 02  Filed by: Hunt Jonathan Robert</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Hunt+Jonathan+Robert/26111905.html</link>
   <description>si-local-file:///var/storage/secattach/20260304/26111905.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Perspective+Therapeutics++For%3A+Mar+02++Filed+by%3A+Hunt+Jonathan+Robert/26111905.html</guid>
   <pubDate>Wed, 04 Mar 2026 16:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Piper Sandler Starts Perspective Therapeutics Inc (CATX) at Overweight</title>
   <link>http://www.streetinsider.com/New+Coverage/Piper+Sandler+Starts+Perspective+Therapeutics+Inc+%28CATX%29+at+Overweight/26025080.html</link>
   <description>&lt;p&gt;Piper Sandler analyst Biren Amin initiates coverage on Perspective Therapeutics Inc (NYSE: CATX) with a Overweight rating and a price target of $16.00.&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;We are initiating coverage on Perspective Therapeutics (CATX) with an Overweight rating and $16 PT. The company's pipeline of lead-212 radiotherapies harnesses alpha radiation (superior potency vs. beta-emitters) with a differentiated safety profile enabled by a proprietary net-neutral chelator. The lead asset VMT-α-NET targets SSTR2, with early dose-escalation data in NETs comparing favorably to SOC Lutathera (39% ORR vs. Lutathera's 13%). Critically, VMT-α-NET has reported zero serious renal events or dysphagia to date (TRAEs that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/New+Coverage/Piper+Sandler+Starts+Perspective+Therapeutics+Inc+%28CATX%29+at+Overweight/26025080.html</guid>
   <pubDate>Thu, 19 Feb 2026 05:31:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	  </item>
  <item>
   <title>Piper Sandler Starts Perspective Therapeutics Inc (CATX) at Overweight</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Piper+Sandler+Starts+Perspective+Therapeutics+Inc+%28CATX%29+at+Overweight/26025080.html</link>
   <description>&lt;p&gt;Piper Sandler analyst Biren Amin initiates coverage on Perspective Therapeutics Inc (NYSE: CATX) with a Overweight rating and a price target of $16.00.&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;We are initiating coverage on Perspective Therapeutics (CATX) with an Overweight rating and $16 PT. The company's pipeline of lead-212 radiotherapies harnesses alpha radiation (superior potency vs. beta-emitters) with a differentiated safety profile enabled by a proprietary net-neutral chelator. The lead asset VMT-α-NET targets SSTR2, with early dose-escalation data in NETs comparing favorably to SOC Lutathera (39% ORR vs. Lutathera's 13%). Critically, VMT-α-NET has reported zero serious renal events or dysphagia to date (TRAEs that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Piper+Sandler+Starts+Perspective+Therapeutics+Inc+%28CATX%29+at+Overweight/26025080.html</guid>
   <pubDate>Thu, 19 Feb 2026 05:31:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	  </item>
  <item>
   <title>Perspective Therapeutics Inc (CATX) PT Raised to $18 at RBC Capital</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Perspective+Therapeutics+Inc+%28CATX%29+PT+Raised+to+%2418+at+RBC+Capital/26007388.html</link>
   <description>RBC Capital analyst Leonid Timashev raised the price target on Perspective Therapeutics Inc (NYSE: CATX) to $18.00  (from $16.00) while maintaining a Outperform rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Perspective+Therapeutics+Inc+%28CATX%29+PT+Raised+to+%2418+at+RBC+Capital/26007388.html</guid>
   <pubDate>Tue, 17 Feb 2026 08:54:06 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  Perspective Therapeutics               Filed by: MORGAN STANLEY</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Perspective+Therapeutics+++++++++++++++Filed+by%3A+MORGAN+STANLEY/25989418.html</link>
   <description>si-local-file:///var/storage/secattach/20260212/25989418.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Perspective+Therapeutics+++++++++++++++Filed+by%3A+MORGAN+STANLEY/25989418.html</guid>
   <pubDate>Thu, 12 Feb 2026 10:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  Perspective Therapeutics               Filed by: MORGAN STANLEY</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Perspective+Therapeutics+++++++++++++++Filed+by%3A+MORGAN+STANLEY/25989418.html</link>
   <description>si-local-file:///var/storage/secattach/20260212/25989418.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Perspective+Therapeutics+++++++++++++++Filed+by%3A+MORGAN+STANLEY/25989418.html</guid>
   <pubDate>Thu, 12 Feb 2026 10:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  Perspective Therapeutics               Filed by: Commodore Capital LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Perspective+Therapeutics+++++++++++++++Filed+by%3A+Commodore+Capital+LP/25968791.html</link>
   <description>si-local-file:///var/storage/secattach/20260209/25968791.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Perspective+Therapeutics+++++++++++++++Filed+by%3A+Commodore+Capital+LP/25968791.html</guid>
   <pubDate>Mon, 09 Feb 2026 16:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  Perspective Therapeutics               Filed by: Commodore Capital LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Perspective+Therapeutics+++++++++++++++Filed+by%3A+Commodore+Capital+LP/25968791.html</link>
   <description>si-local-file:///var/storage/secattach/20260209/25968791.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Perspective+Therapeutics+++++++++++++++Filed+by%3A+Commodore+Capital+LP/25968791.html</guid>
   <pubDate>Mon, 09 Feb 2026 16:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CATX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00064612</category>
   	  </item>
 </channel>
</rss>
